Albinism: epidemiology, genetics, cutaneous characterization, psychosocial factors.
Marçon CR, Maia M.
An Bras Dermatol. 2019 Sep-Oct;94(5):503-520. doi: 10.1016/j.abd.2019.09.023. Epub 2019 Sep 30.
Oculocutaneous albinism.
Grønskov K, Ek J, Brondum-Nielsen K.
Orphanet J Rare Dis. 2007 Nov 2;2:43. doi: 10.1186/1750-1172-2-43.
Albinism.
Federico JR, Krishnamurthy K.
2023 Aug 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Molecular characterization of a series of 990 index patients with albinism.
Lasseaux E, Plaisant C, Michaud V, Pennamen P, Trimouille A, Gaston L, Monfermé S, Lacombe D, Rooryck C, Morice-Picard F, Arveiler B.
Pigment Cell Melanoma Res. 2018 Jul;31(4):466-474. doi: 10.1111/pcmr.12688. Epub 2018 Feb 14.
Oculocutaneous albinism.
Okulicz JF, Shah RS, Schwartz RA, Janniger CK.
J Eur Acad Dermatol Venereol. 2003 May;17(3):251-6. doi: 10.1046/j.1468-3083.2003.00767.x.
Albinism.
François J.
Ophthalmologica. 1979;178(1-2):19-31. doi: 10.1159/000308802.
Albinism.
Kinnear PE, Jay B, Witkop CJ Jr.
Surv Ophthalmol. 1985 Sep-Oct;30(2):75-101. doi: 10.1016/0039-6257(85)90077-3.
Albinism: an update.
Orlow SJ.
Semin Cutan Med Surg. 1997 Mar;16(1):24-9. doi: 10.1016/s1085-5629(97)80032-6.
Authors' reply.
Rambhia KD, Chowdhary S, Rao GV, Khopkar US.
Indian J Dermatol Venereol Leprol. 2018 Sep-Oct;84(5):584. doi: 10.4103/ijdvl.IJDVL_451_18.
Current landscape of Oculocutaneous Albinism in Japan.
Okamura K, Suzuki T.
Pigment Cell Melanoma Res. 2021 Mar;34(2):190-203. doi: 10.1111/pcmr.12927. Epub 2020 Oct 7.
